Exploiting endocytic pathways to prevent bacterial toxin infection

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2015, Pages 1072-1094

  Harper, Callista B ^a   McCluskey, Adam ^b   Robinson, Phillip J ^c   Meunier, Frederic A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bacterial toxins; Clathrin mediated endocytosis (CME); Dynamin; Endocytosis; Membrane trafficking; Small molecule inhibitors

Indexed keywords

EID: 84955515930     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800188-2.00037-9     Document Type: Chapter

References (130)

1. Geny B, Popoff MR Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol Cell 2006, 98(11):667-678.
2. Sandvig K, Bergan J, Kavaliauskiene S, Skotland T Lipid requirements for entry of protein toxins into cells. Prog Lipid Res 2014, 54:1-13.
3. Harper CB, Popoff MR, McCluskey A, Robinson PJ, Meunier FA Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors. Trends Cell Biol 2013, 23(2):90-101.
4. Ferguson SM, De Camilli P Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 2012, 13(2):75-88.
5. von Kleist L, Stahlschmidt W, Bulut H, Gromova K, Puchkov D, Robertson MJ, et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 2011, 146(3):471-484.
6. Abrami L, Bischofberger M, Kunz B, Groux R, van der Goot FG Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors. PLoS Pathog 2010, 6(3):e1000792.
7. Gillespie EJ, Ho CL, Balaji K, Clemens DL, Deng G, Wang YE, et al. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc Natl Acad Sci USA 2013, 110(50):E4904-E4912.
8. Slater LH, Hett EC, Mark K, Chumbler NM, Patel D, Lacy DB, et al. Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death. ACS Chem Biol 2013, 8(4):812-822.
9. Zhu PJ, Hobson JP, Southall N, Qiu C, Thomas CJ, Lu J, et al. Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death. Bioorg Med Chem 2009, 17(14):5139-5145.
10. Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PloS One 2010, 5(5):e10673.
11. Opota O, Gauthier NC, Doye A, Berry C, Gounon P, Lemichez E, et al. Bacillus sphaericus binary toxin elicits host cell autophagy as a response to intoxication. PloS One 2011, 6(2):e14682.
12. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, et al. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312(5773):592-596.
13. Harper CB, Martin S, Nguyen TH, Daniels SJ, Lavidis NA, Popoff MR, et al. Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem 2011, 286(41):35966-35976.
14. Gibert M, Monier MN, Ruez R, Hale ML, Stiles BG, Benmerah A, et al. Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cell Microbiol 2011, 13(1):154-170.
15. Pust S, Barth H, Sandvig K Clostridium botulinum C2 toxin is internalized by clathrin- and Rho-dependent mechanisms. Cell Microbiol 2010, 12(12):1809-1820.
16. Krishnan M, Kannan TR, Baseman JB Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis. PloS One 2013, 8(5):e62706.
17. Torgersen ML, Skretting G, van Deurs B, Sandvig K Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 2001, 114(Pt 20):3737-3747.
18. Massol RH, Larsen JE, Fujinaga Y, Lencer WI, Kirchhausen T Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways. Mol Biol Cell 2004, 15(8):3631-3641.
19. Howes MT, Kirkham M, Riches J, Cortese K, Walser PJ, Simpson F, et al. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol 2010, 190(4):675-691.
20. Saenz JB, Doggett TA, Haslam DB Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect Immun 2007, 75(9):4552-4561.
21. Cortes-Bratti X, Chaves-Olarte E, Lagergard T, Thelestam M Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect Immun 2000, 68(12):6903-6911.
22. Guerra L, Teter K, Lilley BN, Stenerlow B, Holmes RK, Ploegh HL, et al. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 2005, 7(7):921-934.
23. Gargi A, Tamilselvam B, Powers B, Prouty MG, Lincecum T, Eshraghi A, et al. Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J Biol Chem 2013, 288(11):7492-7505.
24. Contamin S, Galmiche A, Doye A, Flatau G, Benmerah A, Boquet P The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step. Mol Biol Cell 2000, 11(5):1775-1787.
25. Deng Q, Zhang Y, Barbieri JT Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin. Traffic 2007, 8(10):1331-1345.
26. Smith DC, Spooner RA, Watson PD, Murray JL, Hodge TW, Amessou M, et al. Internalized pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 2006, 7(4):379-393.
27. Atapattu DN, Czuprynski CJ Mannheimia haemolytica leukotoxin binds to lipid rafts in bovine lymphoblastoid cells and is internalized in a dynamin-2- and clathrin-dependent manner. Infect Immun 2007, 75(10):4719-4727.
28. Locht C, Coutte L, Mielcarek N The ins and outs of pertussis toxin. FEBS J. 2011, 278(23):4668-4682.
29. Navarro-Garcia F, Canizalez-Roman A, Vidal JE, Salazar MI Intoxication of epithelial cells by plasmid-encoded toxin requires clathrin-mediated endocytosis. Microbiology 2007, 153(Pt 9):2828-2838.
30. Repella TL, Ho M, Chong TP, Bannai Y, Wilson BA Arf6-dependent intracellular trafficking of Pasteurella multocida toxin and pH-dependent translocation from late endosomes. Toxins 2011, 3(3):218-241.
31. Romer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007, 450(7170):670-675.
32. Romer W, Pontani LL, Sorre B, Rentero C, Berland L, Chambon V, et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis. Cell 2010, 140(4):540-553.
33. Johannes L, Romer W Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol 2010, 8(2):105-116.
34. Stechmann B, Bai SK, Gobbo E, Lopez R, Merer G, Pinchard S, et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 2010, 141(2):231-242.
35. Mukhopadhyay S, Linstedt AD Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 2012, 335(6066):332-335.
36. Mukhopadhyay S, Redler B, Linstedt AD Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms. Mol Biol Cell 2013, 24(15):2311-2318.
37. Deinhardt K, Berninghausen O, Willison HJ, Hopkins CR, Schiavo G Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol 2006, 174(3):459-471.
38. Blum FC, Chen C, Kroken AR, Barbieri JT Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect Immun 2012, 80(5):1662-1669.
39. Yeh FL, Dong M, Yao J, Tepp WH, Lin G, Johnson EA, et al. SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog 2010, 6(11):e1001207.
40. Gauthier NC, Monzo P, Kaddai V, Doye A, Ricci V, Boquet P Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol Biol Cell 2005, 16(10):4852-4866.
41. Doherty GJ, McMahon HT Mechanisms of endocytosis. Annu Rev Biochem 2009, 78:857-902.
42. Lemichez E, Bomsel M, Devilliers G, vanderSpek J, Murphy JR, Lukianov EV, et al. Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery. Mol Microbiol 1997, 23(3):445-457.
43. Abrami L, Liu S, Cosson P, Leppla SH, van der Goot FG Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 2003, 160(3):321-328.
44. Boll W, Ehrlich M, Collier RJ, Kirchhausen T Effects of dynamin inactivation on pathways of anthrax toxin uptake. Eur J Cell Biol 2004, 83(6):281-288.
45. Abrami L, Kunz B, van der Goot FG Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. Proc Natl Acad Sci USA 2010, 107(4):1420-1424.
46. Huber M, Brabec M, Bayer N, Blaas D, Fuchs R Elevated endosomal pH in HeLa cells overexpressing mutant dynamin can affect infection by pH-sensitive viruses. Traffic 2001, 2(10):727-736.
47. Parton RG Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994, 42(2):155-166.
48. Tran D, Carpentier JL, Sawano F, Gorden P, Orci L Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci USA 1987, 84(22):7957-7961.
49. Orlandi PA, Fishman PH Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998, 141(4):905-915.
50. Wolf AA, Fujinaga Y, Lencer WI Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol. J Biol Chem 2002, 277(18):16249-16256.
51. Broeck DV, Lagrou AR, De Wolf MJ Distinct role of clathrin-mediated endocytosis in the functional uptake of cholera toxin. Acta Biochim Pol 2007, 54(4):757-767.
52. Shogomori H, Futerman AH Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 2001, 276(12):9182-9188.
53. Boquet P, Ricci V Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol 2012, 20(4):165-174.
54. Renard HF, Simunovic M, Lemière J, Boucrot E, Garcia-Castillo MD, Arumugam S, et al. Nature 2015, 517(7535):493-496.
55. Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 2008, 19(12):5226-5237.
56. Rummel A, Hafner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, et al. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem 2009, 110(6):1942-1954.
57. Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 2009, 48(24):5631-5641.
58. Peng L, Tepp WH, Johnson EA, Dong M Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog 2011, 7(3):e1002008.
59. Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, et al. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 1994, 269(14):10498-10503.
60. Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, et al. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett 1996, 378(3):253-257.
61. Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 2003, 162(7):1293-1303.
62. Rummel A, Karnath T, Henke T, Bigalke H, Binz T Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 2004, 279(29):30865-30870.
63. Dong M, Tepp WH, Liu H, Johnson EA, Chapman ER Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol 2007, 179(7):1511-1522.
64. Rummel A Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 2013, 364:61-90.
65. Strotmeier J, Gu S, Jutzi S, Mahrhold S, Zhou J, Pich A, et al. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol Microbiol 2011, 81(1):143-156.
66. Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J Biol Chem 2012, 287(48):40806-40816.
67. Peng L, Berntsson RP, Tepp WH, Pitkin RM, Johnson EA, Stenmark P, et al. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J Cell Sci 2012, 125(Pt 13):3233-3242.
68. Rossetto O, Pirazzini M, Montecucco C Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 2014, 12(8):535-549.
69. Pirazzini M, Tehran DA, Zanetti G,Megighian A, Scorzeto M, Fillo S, et al. Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep. in press.
70. Brunger AT, Breidenbach MA, Jin R, Fischer A, Santos JS, Montal M Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain. PLoS Pathog 2007, 3(9):1191-1194.
71. Koriazova LK, Montal M Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 2003, 10(1):13-18.
72. Dover N, Barash JR, Hill KK, Xie G, Arnon SS Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 2014, 209(2):192-202.
73. Barash JR, Arnon SS A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 2014, 209(2):183-191.
74. Newton AJ, Kirchhausen T, Murthy VN Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci USA 2006, 103(47):17955-17960.
75. Raimondi A, Ferguson SM, Lou X, Armbruster M, Paradise S, Giovedi S, et al. Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron 2011, 70(6):1100-1114.
76. Matteoli M, Verderio C, Rossetto O, Iezzi N, Coco S, Schiavo G, et al. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc Natl Acad Sci USA 1996, 93(23):13310-13315.
77. Bohnert S, Schiavo G Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J Biol Chem. 2005, 280(51):42336-42344.
78. Hamon MA, Ribet D, Stavru F, Cossart P Listeriolysin O: the Swiss army knife of Listeria. Trend Microbiol 2012, 20(8):360-368.
79. Gatsogiannis C, Lang AE, Meusch D, Pfaumann V, Hofnagel O, Benz R, et al. A syringe-like injection mechanism in Photorhabdus luminescens toxins. Nature 2013, 495(7442):520-523.
80. Landsberg MJ, Jones SA, Rothnagel R, Busby JN, Marshall SD, Simpson RM, et al. 3D structure of the Yersinia entomophaga toxin complex and implications for insecticidal activity. Proc Natl Acad Sci USA 2011, 108(51):20544-20549.
81. Albert MA, Kojic LD, Nabi IR, Dubreuil JD Cell type-dependent internalization of the Escherichia coli STb enterotoxin. FEMS Immunol Med Microbiol 2011, 61(2):205-217.
82. Fennessey CM, Sheng J, Rubin DH, McClain MS Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2. PloS One 2012, 7(10):e46866.
83. Stiles BG, Barth G, Barth H, Popoff MR Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?. Toxins (Basel) 2013, 5(11):2138-2160.
84. Hill TA, Odell LR, Quan A, Abagyan R, Ferguson G, Robinson PJ, et al. Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity. Bioorg Med Chem Lett 2004, 14(12):3275-3278.
85. Hill T, Odell LR, Edwards JK, Graham ME, McGeachie AB, Rusak J, et al. Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins. J Med Chem 2005, 48(24):7781-7788.
86. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006, 10(6):839-850.
87. Quan A, McGeachie AB, Keating DJ, van Dam EM, Rusak J, Chau N, et al. Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. Mol Pharmacol 2007, 72(6):1425-1439.
88. Hill TA, Gordon CP, McGeachie AB, Venn-Brown B, Odell LR, Chau N, et al. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles. J Med Chem 2009, 52(12):3762-3773.
89. Hill TA, Mariana A, Gordon CP, Odell LR, Robertson MJ, McGeachie AB, et al. Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis. J Med Chem 2010, 53(10):4094-4102.
90. Joshi S, Perera S, Gilbert J, Smith CM, Mariana A, Gordon CP, et al. The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells. Mol Cancer Ther 2010, 9(7):1995-2006.
91. Odell LR, Howan D, Gordon CP, Robertson MJ, Chau N, Mariana A, et al. The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening. J Med Chem 2010, 53(14):5267-5280.
92. Chircop M, Perera S, Mariana A, Lau H, Ma MP, Gilbert J, et al. Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells. Mol Cancer Ther 2011, 10(9):1553-1562.
93. Daniel JA, Malladi CS, Kettle E, McCluskey A, Robinson PJ Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nat Protoc 2012, 7(8):1439-1455.
94. Robertson MJ, Hadzic G, Ambrus J, Pome DY, Hyde E, Whiting A, et al. The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity. ACS Med Chem Lett 2012, 3(5):352-356.
95. McCluskey A, Daniel JA, Hadzic G, Chau N, Clayton EL, Mariana A, et al. Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic 2013, 14(12):1272-1289.
96. McGeachie AB, Odell LR, Quan A, Daniel JA, Chau N, Hill TA, et al. Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors. ACS Chem Biol 2013, 8(7):1507-1518.
97. Robertson MJ, Deane FM, Robinson PJ, McCluskey A Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase. Nat Protoc 2014, 9(4):851-870.
98. MacGregor KA, Abdel-Hamid MK, Odell LR, Chau N, Mariana A, Robinson PJ, et al. Development of quinone-based analogues as a new class of dynamin GTPase inhibitors. Eur J Med Chem 2014, 85:191-206.
99. Carter GC, Bernstone L, Baskaran D, James W HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 2011, 409(2):234-250.
100. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137(3):433-444.
101. Park RJ, Shen H, Liu L, Liu X, Ferguson SM, De Camilli P Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. J Cell Sci 2013, 126(Pt 22):5305-5312.
102. Smith CM, Haucke V, McCluskey A, Robinson PJ, Chircop M Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells. Mol Cancer 2013, 12:4.
103. Robertson MJ, Deane FM, Stahlschmidt W, von Kleist L, Haucke V, Robinson PJ, et al. Synthesis of the Pitstop family of clathrin inhibitors. Nature Protoc 2014, 9(7):1592-1606.
104. MacGregor KA, Robertson MJ, Young KA, von Kleist L, Stahlschmidt W, Whiting A, et al. Development of 1,8-naphthalimides as clathrin inhibitors. J Med Chem 2014, 57(1):131-143.
105. Dutta D, Williamson CD, Cole NB, Donaldson JG Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PloS One 2012, 7(9):e45799.
106. Willox AK, Sahraoui YM, Royle SJ Non-specificity of Pitstop 2 in clathrin-mediated endocytosis. Biol Open 2014, 3(5):326-331.
107. Stahlschmidt W, Robertson MJ, Robinson PJ, McCluskey A, Haucke V Clathrin terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors mediated by AP-1 and GGA adaptors. J Biol Chem 2014, 289(8):4906-4918.
108. Abdel-Hamid MK, McCluskey A In silico docking, molecular dynamics and binding energy insights into the bolinaquinone-clathrin terminal domain binding site. Molecules 2014, 19(5):6609-6622.
109. Fischer A, Nakai Y, Eubanks LM, Clancy CM, Tepp WH, Pellett S, et al. Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc Natl Acad Sci USA 2009, 106(5):1330-1335.
110. Bezrukov SM, Liu X, Karginov VA, Wein AN, Leppla SH, Popoff MR, et al. Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins. Biophys J 2012, 103(6):1208-1217.
111. Bronnhuber A, Maier E, Riedl Z, Hajos G, Benz R, Barth H Inhibitions of the translocation pore of Clostridium botulinum C2 toxin by tailored azolopyridinium salts protects human cells from intoxication. Toxicology 2014, 316:25-33.
112. Beitzinger C, Bronnhuber A, Duscha K, Riedl Z, Huber-Lang M, Benz R, et al. Designed azolopyridinium salts block protective antigen pores in vitro and protect cells from anthrax toxin. PloS One 2013, 8(6):e66099.
113. Backer MV, Patel V, Jehning BT, Claffey KP, Karginov VA, Backer JM Inhibition of anthrax protective antigen outside and inside the cell. Antimicrob Agents Chemother 2007, 51(1):245-251.
114. Karginov VA, Nestorovich EM, Moayeri M, Leppla SH, Bezrukov SM Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. Proc Natl Acad Sci USA 2005, 102(42):15075-15080.
115. Karginov VA, Nestorovich EM, Schmidtmann F, Robinson TM, Yohannes A, Fahmi NE, et al. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives. Bioorg Med Chem 2007, 15(16):5424-5431.
116. Karginov VA, Nestorovich EM, Yohannes A, Robinson TM, Fahmi NE, Schmidtmann F, et al. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities. Antimicrob Agents Chemother 2006, 50(11):3740-3753.
117. Karginov VA, Yohannes A, Robinson TM, Fahmi NE, Alibek K, Hecht SM Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin. Bioorg Med Chem 2006, 14(1):33-40.
118. Moayeri M, Robinson TM, Leppla SH, Karginov VA In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin. Antimicrob Agents Chemother 2008, 52(6):2239-2241.
119. Nestorovich EM, Karginov VA, Berezhkovskii AM, Bezrukov SM Blockage of anthrax PA63 pore by a multicharged high-affinity toxin inhibitor. Biophys J 2010, 99(1):134-143.
120. Nestorovich EM, Karginov VA, Popoff MR, Bezrukov SM, Barth H Tailored ss-cyclodextrin blocks the translocation pores of binary exotoxins from C. botulinum and C. perfringens and protects cells from intoxication. PloS One 2011, 6(8):e23927.
121. Pirazzini M, Henke T, Rossetto O, Mahrhold S, Krez N, Rummel A, et al. Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain. FEBS Lett 2013, 587(23):3831-3836.
122. Gupta N, Pons V, Noel R, Buisson DA, Michau A, Johannes L, et al. (S)-N-Methyldihydroquinazolinones are the Active Enantiomers of Retro-2 Derived Compounds against Toxins. ACS Med Chem Lett 2014, 5(1):94-97.
123. Noel R, Gupta N, Pons V, Goudet A, Garcia-Castillo MD, Michau A, et al. N-methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin. J Med Chem 2013, 56(8):3404-3413.
124. Morinaga N, Yahiro K, Noda M Resveratrol, a natural polyphenolic compound, inhibits cholera toxin-induced cyclic AMP accumulation in Vero cells. Toxicon 2010, 56(1):29-35.
125. Morinaga N, Iwamaru Y, Yahiro K, Tagashira M, Moss J, Noda M Differential activities of plant polyphenols on the binding and internalization of cholera toxin in vero cells. J Biol Chem 2005, 280(24):23303-23309.
126. Yahiro K, Shirasaka D, Tagashira M, Wada A, Morinaga N, Kuroda F, et al. Inhibitory effects of polyphenols on gastric injury by Helicobacter pylori VacA toxin. Helicobacter 2005, 10(3):231-239.
127. Krautz-Peterson G, Chapman-Bonofiglio S, Boisvert K, Feng H, Herman IM, Tzipori S, et al. Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody. Infect Immun 2008, 76(5):1931-1939.
128. Yermakova A, Klokk TI, Cole R, Sandvig K, Mantis NJ Antibody-mediated inhibition of ricin toxin retrograde transport. MBio 2014, 5(2):e00995.
129. Masaike Y, Takagi T, Hirota M, Yamada J, Ishihara S, Yung TM, et al. Identification of dynamin-2-mediated endocytosis as a new target of osteoporosis drugs, bisphosphonates. Mol Pharmacol 2010, 77(2):262-269.
130. Otomo M, Takahashi K, Miyoshi H, Osada K, Nakashima H, Yamaguchi N Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase). Biol Pharm Bull 2008, 31(8):1489-1495.